![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DB Wainscott, ML Cohen, KW Schenck, JE Audia, JS Nissen, M Baez, JD Kursar, VL Lucaites and DL Nelson
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
The rat 5-hydroxytryptamine (5-HT)2F (serotonin2F) receptor is a newly cloned member of the 5-HT2/1C receptor family. The pharmacology of the 5-HT2F receptor was explored using a variety of structurally different compounds in a radioligand binding assay. In addition, the 5-HT2F receptor was shown to stimulate production of inositol 1,4,5- trisphosphate in the transformed cells. Based on the affinities of the compounds tested, their known affinities for certain of the other 5-HT receptors, and the fact that activation of the cloned 5-HT2F receptor stimulates inositol 1,4,5-trisphosphate production, the 5-HT2F receptor was determined to be a novel receptor and a member of the 5-HT2/1C receptor family. In addition, several agonists and partial agonists were evaluated for contractile activity in the rat stomach fundus, and these activities were correlated with their binding affinities at the 5- HT2F receptor. A highly significant correlation was found, providing additional evidence that is consistent with the 5-HT2F receptor being the stomach fundal contractile receptor. [3H]5-HT had high affinity for this receptor both at 37 degrees and at 0 degree (Kd = 7.87 +/- 0.55 and 0.12 +/- 0.02 nM, respectively). The difference in affinity for [3H]5-HT at the two temperatures prompted an investigation of potential temperature-dependent differences in the binding affinities of agonists versus antagonists. Agonists such as 5-HT, 5-methoxytryptamine, etc., showed higher affinity for the 5-HT2F receptor at 0 degree than at 37 degrees, whereas antagonists such as methysergide, 1- naphthylpiperazine, etc., showed no difference in affinity for this receptor at the two different temperatures. Therefore, the affinity of a compound for the 5-HT2F receptor at 37 degrees versus 0 degree was shown to be useful for predicting agonist or antagonist activity. Additionally, information is provided about some of the structural requirements for the affinity of certain tryptamines at the 5-HT2F receptor.
This article has been cited by other articles:
|
|
 |
|
  E. Qvigstad, I. Sjaastad, T. Brattelid, C. Nunn, F. Swift, J. A. K. Birkeland, K. A. Krobert, G. O. Andersen, O. M. Sejersted, J.-B. Osnes, et al. Dual Serotonergic Regulation of Ventricular Contractile Force Through 5-HT2A and 5-HT4 Receptors Induced in the Acute Failing Heart Circ. Res., August 5, 2005; 97(3): 268 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Watts and J. M. Thompson Characterization of the Contractile 5-Hydroxytryptamine Receptor in the Renal Artery of the Normotensive Rat J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 165 - 172. [Abstract] [Full Text]
|
|
|
|
|
|
A. Russell, A. Banes, H. Berlin, G. D. Fink, and S. W. Watts 5-Hydroxytryptamine2B Receptor Function Is Enhanced in the Nomega -Nitro-L-arginine Hypertensive Rat J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 179 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Watts Serotonin-Induced Contraction in Mesenteric Resistance Arteries: Signaling and Changes in Deoxycorticosterone Acetate-Salt Hypertension Hypertension, March 1, 2002; 39(3): 825 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. McKune and S. W. Watts Characterization of the Serotonin Receptor Mediating Contraction in the Mouse Thoracic Aorta and Signal Pathway Coupling J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 88 - 95. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. Contesse, S. Lenglet, L. Grumolato, Y. Anouar, I. Lihrmann, H. Lefebvre, C. Delarue, and H. Vaudry Pharmacological and Molecular Characterization of 5-Hydroxytryptamine7 Receptors in the Rat Adrenal Gland Mol. Pharmacol., September 1, 1999; 56(3): 552 - 561. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. W. Watts and G. D. Fink 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H944 - H952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Chen, M. R. Vasko, X. Wu, T. P. Staeva, M. Baez, J. M. Zgombick, and D. L. Nelson Multiple Subtypes of Serotonin Receptors Are Expressed in Rat Sensory Neurons in Culture J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1119 - 1127. [Abstract] [Full Text]
|
|
|
|
|
|
S. W. Watts, L. Gilbert, and R. C. Webb 5-Hydroxytryptamine2B Receptor Mediates Contraction in the Mesenteric Artery of Mineralocorticoid Hypertensive Rats Hypertension, December 1, 1995; 26(6): 1056 - 1059. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
